Histochemical characteristics on minimodeling-based bone formation in-duced by anabolic drugs for osteoporotic treatment

Tomomaya Yamamoto,Tomoka Hasegawa,Paulo Henrique Luiz de Fraitas,Hiromi Hongo,Shen Zhao,Tsuneyuki Yamamoto,Alireza Nasoori,Miki Abe,Haruhi Maruoka,Keisuke Kubota,Yasuhito Morimoto,Mai Haraguchi,Tomohiro Shimizu,Masahiko Takahata,Norimasa Iwasaki,Minqi Li,Norio Amizuka
DOI: https://doi.org/10.2220/biomedres.42.161
2021-01-01
Abstract:Modeling, the changes of bone size and shape, often takes place at the developmental stages, whereas bone remodeling-replacing old bone with new bone-predominantly occurs in adults. Unlike bone remodeling, bone formation induced by modeling i.e., minimodeling (microscopic modeling in cancellous bone) is independent of osteoclastic bone resorption. Although recently-developed drugs for osteoporotic treatment could induce minimodeling-based bone formation in addition to remodeling-based bone formation, few reports have demonstrated the histological aspects of minimodeling-based bone formation. After administration of eldecalcitol or romosozumab, unlike teriparatide treatment, mature osteoblasts formed new bone by minimodeling, without developing thick preosteoblastic layers. The histological characteristics of minimodeling-based bone formation is quite different from remodeling, as it is not related to osteoclastic bone resorption, resulting in convex-shaped new bone and smooth cement lines called arrest lines. In this review, we will show histological properties of minimodeling-based bone formation by osteoporotic drugs.
What problem does this paper attempt to address?